ΔNp63 regulates IL-33 and IL-31 signaling in atopic dermatitis
Jason M. Rizzo(University at Buffalo, State University of New York), Emma Guttman‐Yassky(Icahn School of Medicine at Mount Sinai), Satrajit Sinha(University at Buffalo, State University of New York), Jonathan Bard(University at Buffalo, State University of New York), Kirsten Smalley(University at Buffalo, State University of New York), Anna De Benedetto(University of Rochester Medicine), Sangwon Min(Harvard University), Akinsola Oyelakin(Seattle Children's Hospital), Takeshi Yoshida(University of Rochester Medicine), Lisa A. Beck(University of Rochester Medicine), John Nyquist(University at Buffalo, State University of New York), Wei Luo(Jiangnan University)
Cited by 52
Related Papers
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Atopic dermatitis
|Nature Reviews Disease Primers|2018|1.5k
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
|New England Journal of Medicine|2014|1.4k
Cytokine modulation of atopic dermatitis filaggrin skin expression
|Journal of Allergy and Clinical Immunology|2007|1.1k